Cephasonics
Cephasonics develops and manufactures ultrasound technology that can be enhanced by custom, 3D printed transducer arrays and lenses. They provide an open and flexible platform for developing a wide range of ultrasound-based products.
- CEO / Founder
- Richard Tobias
- Team Size
- 11-50
- Stage
- Active
- Total Funding
- $4.08M
- Latest Round
- Grant
- Key Investors
- National Science Foundation, Sand Hill Angels, Band of Angels
Technology & Products
Key Products
["cQuest Ultrasound Platform","Echo-64 Ultrasound Systems","Custom Ultrasound Probes","Application Development Software"]
Technological Advantage
The company's open and flexible platform, combined with its focus on AI and custom hardware, allows for the rapid development of new and innovative ultrasound applications.
Differentiation
Value Proposition
Providing a high-performance, scalable, and flexible ultrasound platform that enables rapid development and innovation in medical and industrial applications.
How They Differentiate
Cephasonics differentiates itself through its focus on an open and flexible platform, AI integration, and the ability to create custom solutions with 3D printed components.
Market & Competition
Target Customers
Researchers and medical entrepreneurs creating new applications that can recognize, quantify and characterize structures in the body.
Industry Verticals
["Medical","Industrial"]
Competitors
Verasonics; BK Medical; Analogic
Growth & Milestones
Growth Metrics
Received ISO 13485:2016 certification and opened a new manufacturing facility in Blaine, Minnesota.
Major Milestones
["Launched after a buyout of Samplify Systems’ Ultrasound Business Unit in March of 2012.","Received ISO 13485:2016 certification.","Opened a new manufacturing facility in Blaine, Minnesota."]
Notable Customers
Information not readily available.